Legend Biotech Corporation
LEGN
$34.18
-$0.52-1.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 514.11M | 450.18M | 339.35M | 284.96M | 232.98M |
| Total Other Revenue | 6.07M | 5.81M | 3.45M | 179.00K | 330.00K |
| Total Revenue | 520.18M | 455.99M | 342.80M | 285.14M | 233.31M |
| Cost of Revenue | 607.90M | 596.25M | 561.63M | 526.43M | 492.02M |
| Gross Profit | -87.72M | -140.26M | -218.84M | -241.29M | -258.71M |
| SG&A Expenses | 263.52M | 233.15M | 216.92M | 200.93M | 191.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 871.43M | 829.40M | 778.55M | 727.36M | 683.07M |
| Operating Income | -351.24M | -373.41M | -435.76M | -442.22M | -449.75M |
| Income Before Tax | -345.46M | -287.07M | -467.93M | -520.12M | -509.03M |
| Income Tax Expenses | 2.67M | -2.05M | -1.99M | -1.86M | 283.00K |
| Earnings from Continuing Operations | -348.13 | -285.01 | -465.95 | -518.25 | -509.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -348.13M | -285.01M | -465.95M | -518.25M | -509.31M |
| EBIT | -351.24M | -373.41M | -435.76M | -442.22M | -449.75M |
| EBITDA | -340.56M | -362.43M | -425.38M | -431.51M | -439.30M |
| EPS Basic | -3.82 | -3.13 | -5.21 | -5.91 | -5.96 |
| Normalized Basic EPS | -1.18 | -0.99 | -1.63 | -1.85 | -1.86 |
| EPS Diluted | -3.82 | -3.14 | -5.22 | -5.92 | -5.97 |
| Normalized Diluted EPS | -1.18 | -0.99 | -1.63 | -1.85 | -1.86 |
| Average Basic Shares Outstanding | 729.72M | 727.97M | 720.63M | 703.87M | 687.07M |
| Average Diluted Shares Outstanding | 364.86M | 363.99M | 360.31M | 351.94M | 343.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
